Wenqian Wang
Beijing, 100045, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Watchful waiting in children with unifocal osseous Langerhans cell histiocytosis.
Journal: The oncologist
Published: October 20, 2025
Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis.
Journal: Pediatric blood & cancer
Published: August 25, 2025
Long-Term Outcomes of a Stratified Treatment Regimen Based on Etoposide and Glucocorticoids in Children With Hemophagocytic Lymphohistiocytosis (CCHG-HLH-2018): A Multicenter, Single-Arm Clinical Study.
Journal: American journal of hematology
Published: April 19, 2025
Efficacy and safety of ruxolitinib-based regimen in the treatment of paediatric Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Journal: British journal of haematology
Published: January 28, 2025
Ruxolitinib-based regimen in children with autoimmune disease or autoinflammatory disease-related haemophagocytic lymphohistiocytosis.
Journal: British journal of haematology
Published: April 30, 2024
Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone.
Journal: BMC pediatrics
Published: May 07, 2023
Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis.
Journal: Haematologica
Published: May 03, 2023
Epstein-Barr virus-positive diffuse large B-cell lymphoma onset as familial hemophagocytic lymphohistiocytosis in an infant.
Journal: Pediatric blood & cancer
Published: October 20, 2022
Anaplastic lymphoma kinase positive histiocytosis presenting as hemocytopenia in an infant.
Journal: Pediatric blood & cancer
Published: May 22, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026